DI LISA, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 1.187
AS - Asia 893
EU - Europa 223
SA - Sud America 190
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 5
Totale 2.517
Nazione #
US - Stati Uniti d'America 1.136
SG - Singapore 378
CN - Cina 156
BR - Brasile 149
HK - Hong Kong 128
VN - Vietnam 98
IT - Italia 89
FR - Francia 48
BD - Bangladesh 36
CA - Canada 23
GB - Regno Unito 20
IN - India 19
AR - Argentina 14
JP - Giappone 14
KR - Corea 13
FI - Finlandia 11
DE - Germania 9
EC - Ecuador 9
IQ - Iraq 9
MX - Messico 9
CO - Colombia 8
ID - Indonesia 7
NL - Olanda 7
ZA - Sudafrica 7
AE - Emirati Arabi Uniti 6
AT - Austria 6
MY - Malesia 6
SA - Arabia Saudita 6
CR - Costa Rica 4
ES - Italia 4
HN - Honduras 4
RU - Federazione Russa 4
SV - El Salvador 4
TN - Tunisia 4
TR - Turchia 4
CL - Cile 3
IE - Irlanda 3
LT - Lituania 3
BE - Belgio 2
EG - Egitto 2
GT - Guatemala 2
JM - Giamaica 2
KE - Kenya 2
MA - Marocco 2
NP - Nepal 2
PE - Perù 2
PY - Paraguay 2
RO - Romania 2
SI - Slovenia 2
UA - Ucraina 2
VE - Venezuela 2
AL - Albania 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LC - Santa Lucia 1
MM - Myanmar 1
NG - Nigeria 1
NI - Nicaragua 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.513
Città #
Santa Clara 366
Singapore 209
Hong Kong 126
San Jose 122
Ashburn 81
Council Bluffs 62
Lauterbourg 43
Beijing 37
Hefei 33
Ho Chi Minh City 32
New York 26
Hanoi 22
Dallas 19
Abbeville 16
Los Angeles 14
Princeton 13
Seoul 13
Cagliari 12
São Paulo 11
Tokyo 11
Rome 10
Brooklyn 9
Toronto 9
Helsinki 8
Milan 8
Buffalo 7
Naples 7
Atlanta 6
Biên Hòa 6
Chicago 6
Houston 6
Johannesburg 6
Philadelphia 6
Rio de Janeiro 6
Charlotte 5
Fortaleza 5
Nuremberg 5
Pittsburgh 5
Brasília 4
Da Nang 4
Jacksonville 4
Orem 4
Phoenix 4
Quito 4
Austin 3
Belo Horizonte 3
Camaçari 3
Dublin 3
El Paso 3
Fort Worth 3
Frankfurt am Main 3
Lappeenranta 3
Las Vegas 3
London 3
Montreal 3
Newark 3
Ninh Bình 3
Riyadh 3
Sacramento 3
Salvador 3
San Diego 3
San José 3
San Salvador 3
Santo André 3
Temecula 3
Washington 3
Al Ain City 2
Amsterdam 2
Ankara 2
Asunción 2
Avon Park 2
Baghdad 2
Basra 2
Belleville 2
Benito Juarez 2
Birmingham 2
Brussels 2
Bắc Giang 2
Cabo de Santo Agostinho 2
Cairo 2
Can Tho 2
Caracas 2
Chennai 2
Chesapeake 2
City of London 2
Curitiba 2
Dammam 2
Denver 2
Dongguan 2
Erbil 2
Fayetteville 2
Feira de Santana 2
Florence 2
Goiana 2
Greenville 2
Haiphong 2
Hengyang 2
Hải Dương 2
Ituiutaba 2
Jakarta 2
Totale 1.546
Nome #
Confirmation of the Cardioprotective Effect of MitoGamide in the Diabetic Heart 93
Cardioprotection by H2S Donors: Nitric Oxide-Dependent and -Independent Mechanisms 81
European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS) 75
Measurement of mitochondrial ROS formation 68
Identification of an ATP-sensitive potassium channel in mitochondria 68
The unique histidine in OSCP subunit of F-ATP synthase mediates inhibition of the permeability transition pore by acidic pH 67
Pharmacology and Clinical Drug Candidates in Redox Medicine 67
Corrigendum to "European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)" (Redox Biol. (2017) 13 (94-162)(S2213231717303373)(10.1016/j.redox.2017.05.007)) 66
The mitochondrial permeability transition pore and cyclophilin D in cardioprotection 64
Monoamine oxidase-dependent endoplasmic reticulum-mitochondria dysfunction and mast cell degranulation lead to adverse cardiac remodeling in diabetes 63
The Rapidly Evolving Concept of Whole Heart Engineering 62
A novel class of cardioprotective small-molecule PTP inhibitors 61
The energetic cost of NNT-dependent ROS removal 59
Mitochondrial potassium homeostasis: A central player in cardioprotection 58
New aspects of p66Shc in ischaemia reperfusion injury and other cardiovascular diseases 56
On the Clinical Pharmacology of Reactive Oxygen Species 56
Ranolazine attenuates trastuzumab-induced heart dysfunction by modulating ROS production 56
Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery 55
Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection 53
Monoamine Oxidase B Prompts Mitochondrial and Cardiac Dysfunction in Pressure Overloaded Hearts 53
beta(2)-Adrenoceptors, NADPH oxidase, ROS and p38 MAPK: another 'radical' road to heart failure? 52
Pharmacology of oxidative stress: translational opportunities 52
Selective mitochondrial superoxide generation in vivo is cardioprotective through hormesis 51
Reactive Oxygen-Related Diseases: Therapeutic Targets and Emerging Clinical Indications 47
Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs 44
The mitochondrial permeability transition pore: Molecular nature and role as a target in cardioprotection 44
Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction 41
Mitochondria and cardioprotection. 41
The mitochondrial permeability transition from in vitro artifact to disease target. 41
The cardioprotective effects elicited by p66(Shc) ablation demonstrate the crucial role of mitochondrial ROS formation in ischemia/reperfusion injury 39
Enhancement of mitochondrial calcium uptake is cardioprotective against maladaptive hypertrophy by retrograde signaling uptuning Akt 39
Mitochondria and vascular pathology. 39
Evidence of myofibrillar protein oxidation induced by post-ischemic reperfusion in isolated rat hearts. 38
Modulation of mitochondrial K+ permeability and reactive oxygen species production by the p13 protein of human T-cell leukemia virus type 1. 37
Mitochondrial pathways for ROS formation and myocardial injury: the relevance of p66(Shc) and monoamine oxidase 37
The cardioprotective effects elicited by p66(Shc) ablation demonstrate the crucial role of mitochondrial ROS formation in ischemia/reperfusion injury. 37
Monoamine oxidase inhibition prevents mitochondrial dysfunction and apoptosis in myoblasts from patients with collagen VI myopathies 37
Oxidative stress in muscular dystrophy: from generic evidence to specific sources and targets 36
Mitochondria and cardioprotection 36
Induction of the mitochondrial permeability transition by the DNA alkylating agent N-methyl-N '-nitro-N-nitrosoguanidine. Sorting cause and consequence of mitochondrial dysfunction 35
Reactive oxygen species and redox compartmentalization 35
Arachidonic acid released by phospholipase A(2) activation triggers Ca2+-dependent apoptosis through the mitochondrial pathway 35
Mitochondrial function and myocardial aging. A critical analysis of the role of permeability transition 34
The mitochondrial permeability transition from in vitro artifact to disease target 34
Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole. 34
Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury 34
The p66ShcA adaptor protein regulates healing after myocardial infarction 33
Preface to Mitochondria and Cardioprotection 32
Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning 32
Monoamine oxidases as sources of oxidants in the heart 31
Redox regulation of T-cell turnover by the p13 protein of human T-cell leukemia virus type 1: distinct effects in primary versus transformed cells. 31
A CaPful of mechanisms regulating the mitochondrial permeability transition 28
Perspectives on the mitochondrial permeability transition 20
Totale 2.517
Categoria #
all - tutte 9.244
article - articoli 9.014
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 230
Totale 18.488


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025824 0 2 50 32 300 57 4 50 6 13 161 149
2025/20261.174 33 87 128 162 194 57 160 82 44 76 57 94
2026/2027519 68 45 126 274 6 0 0 0 0 0 0 0
Totale 2.517